Safety and preliminary signs of efficacy with the combination of pembrolizumab plus oxaliplatin and S-1 in Japanese gastric cancer patients

Ann Transl Med. 2020 Dec;8(24):1696. doi: 10.21037/atm-20-4725.
No abstract available

Publication types

  • Editorial
  • Comment